About: Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor"associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $19.83 (+1.48%)
ODTX NASDAQ Odyssey Therapeutics, Inc. Common Stock
Odyssey Therapeutics, Inc. Common Stock share price
Atividade de preço de ODTX
Último preço
$ 19,830
Variação (24h)
0,29 USD (1,48%)
Volume
212.73K
Volume (média 4 sem.)
-
Abertura
$ 19,70
Variação do dia
$ 18,70 - $ 20,62
Fechamento anterior
$ 19,54
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ODTX price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals